Backlog Record

AEHR's effective backlog hit a record of $50.9 million, providing significant support for sales to move higher in FY2027. The company has strong relationships in place with AI-processor developers and silicon photonics suppliers, which are experiencing rapid growth in the AI infrastructure market. While AEHR's valuation remains a key risk, analysts at Craig Hallum have upgraded the stock from a Hold to a Buy with a $68 price target.